Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
147.88
+2.11 (1.45%)
Nov 20, 2026, 11:36 AM EST - Market open
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $2.16 billion as of November 20, 2026. It is the 5,981st most valuable company in the world and the 1,654th biggest in the United States. Its market cap has increased by 88.46% in one year.
Market Cap
2.16B
Enterprise Value
1.95B
1-Year Change
88.46%
Global Rank
Country Rank
#1,654 United States
Category
ChartMarket Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $2.16B, an increase of 1,401.55%. That is a compound annual growth rate of 307.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 2.16B | 74.49% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NewAmsterdam Pharma Company | 2.37B |
| Arcus Biosciences | 2.27B |
| Pharvaris | 2.23B |
| Lakefront Biotherapeutics NV | 2.18B |
| Celldex Therapeutics | 2.16B |
| Beam Therapeutics | 2.09B |
| Aurinia Pharmaceuticals | 2.03B |
| Immunome | 1.98B |